Welcome to the Cochrane Dementia and Cognitive Improvement Group, part of Cochrane’s Mental Health and Neuroscience Network.
Our aim is to provide the highest quality evidence about the care and medical treatment of people with dementia, delirium and other cognitive disorders, and about the diagnosis and prevention of these disorders. We do this by producing systematic reviews addressing questions which are important to patients, their families, and healthcare professionals from all disciplines. You can read more about our scope and our work here.
June 2022 News
A new chapter for Cochrane
Cochrane has embarked on an important change programme to transform the way we produce high-quality, independent and timely evidence. The new model is designed to ensure Cochrane remains viable, sustainable, and focused on the greatest global health and care challenges now and into the future.
As part of the new model we are implementing a Central Editorial Service to streamline the editorial process. At the same time, from March 2023, Cochrane Review Groups in the UK will no longer receive NIHR funding. If you are an author currently writing a protocol, review, or update, we are working to ensure a smooth transition with minimal impact on your work.
We are very grateful to everyone who has contributed to the Dementia and Cognitive Improvement group and very much hope that you will continue to give your time and expertise to Cochrane. We encourage you to look out for further communications about Cochrane's plans for the future and new opportunities to get involved. You can stay connected by:
- Following Cochrane on your favourite social media platform
- Opting in to Cochrane email communications in your Cochrane Account
May 2022 News
Drugs for agitation in people with dementia: benefits and risks
In this blog for the families of people with dementia, doctors Charlotte Squires and James Garrard talk about drugs used to treat symptoms of agitation and psychosis in people with diagnosed dementia. They reflect on what doctors and families together might want to consider when making decisions about trying these treatments.
The full blog is available here https://bit.ly/3LykPgS
Dementia diagnosis by phone and video: pitfalls and possibilities
In a blog for people interested in ways to diagnose dementia, and the use of remote methods of assessment, Lucy Beishon, specialist trainee in geriatric medicine and NIHR Academic Clinical Lecturer in Geriatric medicine, talks about evidence on assessing people for dementia by phone and video call, reflects on her experiences during the pandemic, and looks to the future.
The full blog is available here https://buff.ly/39oSegG.
Preventing dementia: what’s the evidence?
In a blog for non-medical people, James Garrard, Specialist Registrar in Geriatric Medicine, looks at the evidence on various drug and non-drug approaches to try and prevent dementia.
The full blog is available here https://bit.ly/38wz1JW